Nanjing, China · Founded 2021 · Privately Held (backing)
Developer and manufacturer of synthetic biotechnology created to provide customers with better products and services. GeneIII is based in Nanjing, China and was founded in 2021. Its last reported valuation was $55.5 million in Jul 2023. It has raised $22.1 million.
Last reported valuation
$55.5M
Oct 2026
Priced at
—
Total raised
$22.1M
Last round
—
Cap table — not yet on record
GeneIII's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GeneIII with a free account
·Watch GeneIII: the Monday email on marks, rounds and moves
